Adverse events1,038

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,038

Type	Event	Organ system	Group	Affected	At risk	Events
other	COVID-19	Infections and infestations	Abelacimab 90 mg (MAA868)	41	425	42
other	COVID-19	Infections and infestations	Abelacimab 150 mg (MAA868)	48	427	49
other	COVID-19	Infections and infestations	Rivaroxaban	45	428	46
other	Atrial fibrillation	Cardiac disorders	Abelacimab 90 mg (MAA868)	28	425	39
other	Atrial fibrillation	Cardiac disorders	Abelacimab 150 mg (MAA868)	27	427	34
other	Atrial fibrillation	Cardiac disorders	Rivaroxaban	24	428	31
other	Arthralgia	Musculoskeletal and connective tissue disorders	Abelacimab 90 mg (MAA868)	23	425	26
other	Arthralgia	Musculoskeletal and connective tissue disorders	Abelacimab 150 mg (MAA868)	26	427	31
other	Arthralgia	Musculoskeletal and connective tissue disorders	Rivaroxaban	27	428	29
other	Hypertension	Vascular disorders	Abelacimab 90 mg (MAA868)	24	425	25
other	Hypertension	Vascular disorders	Abelacimab 150 mg (MAA868)	26	427	27
other	Hypertension	Vascular disorders	Rivaroxaban	20	428	22
other	Back pain	Musculoskeletal and connective tissue disorders	Abelacimab 90 mg (MAA868)	20	425	21
other	Back pain	Musculoskeletal and connective tissue disorders	Abelacimab 150 mg (MAA868)	26	427	29
other	Back pain	Musculoskeletal and connective tissue disorders	Rivaroxaban	22	428	24
other	Urinary tract infection	Infections and infestations	Abelacimab 90 mg (MAA868)	27	425	38
other	Urinary tract infection	Infections and infestations	Abelacimab 150 mg (MAA868)	24	427	27
other	Urinary tract infection	Infections and infestations	Rivaroxaban	12	428	12
other	Anaemia	Blood and lymphatic system disorders	Abelacimab 90 mg (MAA868)	18	425	23
other	Anaemia	Blood and lymphatic system disorders	Abelacimab 150 mg (MAA868)	17	427	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04755283/events

API reference For AI assistants

Adverse events1,038

Sources 3

Read this list from software.